Table 3 Baseline characteristics of the 3Dcohort.
From: KMT2C mutation as a predictor of immunotherapeutic efficacy in colorectal cancer
Characteristics | Total (N = 905) | KMT2C-MUT (n = 111) | KMT2C-WT (n = 794) |
|---|---|---|---|
Age, n (%) | |||
≥ 65 | 273 (30) | 35 (32) | 238 (30) |
< 65 | 632 (70) | 76 (68) | 556 (70) |
Sex, n (%) | |||
Male | 569 (63) | 65 (59) | 504 (63) |
Female | 336 (37) | 46 (41) | 290 (37) |
Primary tumor site, n (%) | |||
Rectum | 316 (35) | 26 (23) | 290 (37) |
Colorectal | 589 (65) | 85 (77) | 504 (63) |
